Edesa Biotech EDSA
NASDAQ EDSA
$2.76 -0.09 (-3.16%)
At close: Oct 22, 2026 · 4:00 PM EDT

Edesa Biotech (EDSA) Receivables - Other (2013 - 2022)

Updated

Edesa Biotech (EDSA) reported Receivables - Other of $1.1 million for fiscal Q4 2022 (quarter ended Sep 30, 2022), down 63.7% from $3.03 million a year earlier and unchanged from the prior quarter.

Analysis

Edesa Biotech (EDSA) Receivables - Other (2013 - 2022) Analysis & Trends

Dating back to fiscal Q4 2013, Edesa Biotech's Receivables - Other record includes 7 quarters.

  • By fiscal year, Receivables - Other came in at $3.03 million in FY2021.
  • Five-year quarterly Receivables - Other spans a low of $1.1 million in fiscal Q2 2022 and a high of $3.99 million in fiscal Q3 2021.
  • Per Business Quant data, the three fiscal quarters before Q4 2022 came in at $1.1 million (Q3 2022), $1.1 million (Q2 2022) and $2.63 million (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Edesa Biotech 24.86 Mn -20.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 1.10 Mn
Jun 30, 2022 1.10 Mn
Mar 31, 2022 1.10 Mn
Dec 31, 2021 2.63 Mn
Sep 30, 2021 3.03 Mn
Jun 30, 2021 3.99 Mn
Aug 31, 2013 157,297.00
API Access

Edesa Biotech Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=EDSA&period=max&api_key=YOUR_API_KEY